Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

To Assess the Effect of Renal Impairment on the Blood Levels of Daclatasvir (DCV), Asunaprevir (ASV) and BMS-791325 After Multiple Doses of a Fixed Dose Combination Tablet

NCT02108639

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +8 more
Locations
  • Clinical Pharmacology Of Miami Inc. Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • Davita Clinical Research Minneapolis, Minnesota, United States
  • New Orleans Center For Clinical Research - Knoxville Knoxville, Tennessee, United States
View Trial Details
Completed

Tipranavir/Ritonavir vs. Genotypically Defined Protease Inhibitor/Ritonavir in HIV Patients (RESIST-2)

NCT00144170

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.48.5401 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5402 Fundación Huésped Buenos Aires, Argentina
  • 1182.48.5403 Servicio de Infecciosas Buenos Aires, Argentina
  • 1182.48.5404 Servicio de Infecciosas Buenos Aires, Argentina
View all 174 locations
View Trial Details
Completed

Randomized Evaluation of Strategic Intervention in Multidrug Resistant Patients With Tipranavir (RESIST)

NCT00054717

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • 1182.12.62 Boehringer Ingelheim Investigational Site Phoenix, Arizona, United States
  • 1182.12.108 El Rio SIA Tucson, Arizona, United States
  • 1182.12.9 Boehringer Ingelheim Investigational Site Berkeley, California, United States
  • 1182.12.23 Boehringer Ingelheim Investigational Site Beverly Hills, California, United States
View all 117 locations
View Trial Details
Completed

Non-interventional Observational Study With Viramune (Nevirapine) and Various Drug Combinations in the Antiretroviral Combination Treatment of HIV-infected Patients Who Have Already Been Treated for Approx. 10 Years With Viramune

NCT00979420

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Boehringer Ingelheim Investigational Site 1 Aachen, Germany
  • Boehringer Ingelheim Investigational Site 10 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 11 Berlin, Germany
  • Boehringer Ingelheim Investigational Site 12 Berlin, Germany
View all 60 locations
View Trial Details
Completed

Safety and Efficacy of the Therapeutic Vaccine GI-5005 Combined With Pegylated Interferon Plus Ribavirin Standard of Care Therapy Versus Standard of Care Alone in Patients With Genotype 1 Chronic Hepatitis C Infection

NCT00606086

Conditions
Blood-Borne Infections, Communicable Diseases, Digestive System Diseases, +9 more
Locations
  • University of Alabama Birmingham Birmingham, Alabama, United States
  • University of Arizona Tucson, Arizona, United States
  • Scripps Clinic Torrey Pines La Jolla, California, United States
  • Research and Education inc. San Diego, California, United States
View all 25 locations
View Trial Details
Completed

A Study of TMC278 in Human Immunodeficiency Virus Type 1 Infected Patients, Who Are Not Treated With Antiretroviral Medicines

NCT00110305

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Beverly Hills, California, United States
  • Washington D.C., District of Columbia, United States
  • Orlando, Florida, United States
  • Tampa, Florida, United States
View all 40 locations
View Trial Details

Related conditions